In re Rezulin Products Liability Litigation

223 F.R.D. 109, 2004 WL 1383549
District Court, S.D. New York·Decided June 21, 2004·No. No. 00 Civ. 2843(LAK)·Published·Cited by 4 cases

Opinion

MEMORANDUM OPINION

KAPLAN, District Judge.

Defendants Warner-Lambert and affiliates move, pursuant to Fed.R.Civ.P. 37(b), for sanctions against several hundred plaintiffs on the ground that they willfully have failed to comply with this Court’s discovery orders. [111]*111The motion was brought only after these plaintiffs thwarted defendants’ efforts to conduct discovery concerning their claims by their persistent failure to provide discovery despite orders of this Court and warning letters from defense counsel. The sanctions sought are dismissal on the merits with prejudice and an injunction under the All Writs Act1 barring the dismissed plaintiffs and their counsel from re-filing their Rezulin actions in any court.

I. Background: The Context of this Motion.

These actions are among thousands seeking recovery in state and federal courts for personal injuries allegedly resulting from the use of the prescription diabetes medication Rezulin, formerly manufactured by defendants Warner-Lambert Co. and its Parke-Davis division. More than one thousand such cases have been consolidated here for pretrial proceedings by the Judicial Panel on Multidistrict Litigation.2

A. Amended Pretrial Order 2 and Pretrial Order J.

Virtually all of the cases before the Court seek recovery for personal injuries. Thus, while plaintiffs’ discovery against the manufacturer defendants concerns predominantly common issues, defendants’ discovery includes inquiry into the particular circumstances of the plaintiff.

At the outset of the litigation, the Court, after obtaining extensive input from counsel, approved a so-called Fact Sheet seeking case specific information such as when the plaintiff took Rezulin, the nature of the medical condition for which it was taken, the nature

of the alleged injuries, and the identities and addresses of medical providers, employers and insurers.3 Each plaintiff was ordered to complete a Fact Sheet under oath and to return it to the defendants with completed authorizations for medical, insurance and employment records. The responses are to be treated as interrogatory answers and are intended to enable the defendants to investigate plaintiffs’ claims and to proceed with depositions, motions or other appropriate measures.

Under Pretrial Order 2, the initial scheduling order,4 plaintiffs in cases that were transferred by the Multidistrict Panel to, and docketed in, this Court on or before December 13, 2000 were obliged to serve completed Fact Sheet responses forty days after approval of the Fact Sheets and thus on or before January 15, 2001.5 Responses by plaintiffs in cases docketed subsequent to December 13, 2000 are due on or before the fortieth day after the docketing of their cases in this Court.6

PTO 2 authorized the defendants to send warning letters to plaintiffs whose disclosures were untimely and/or inadequate, identifying deficiencies in the responses and advising that failure to comply fully with the Order could result in dismissal of plaintiffs’ actions.7 Thus, plaintiffs have known from the outset that noncompliance with Fact Sheet discovery could result in dismissal.

B. Pretrial Order 208

Nevertheless, many plaintiffs failed to serve Fact Sheets or provided materially incomplete responses, e.g., Fact Sheets without sworn declarations and/or authorizations. [112]*112The defendants sent hundreds of deficiency letters seeking compliance and warning of possible sanctions, but these requests and warnings went unheeded by many.

The magnitude of non-compliance became evident in late 2003. Notwithstanding two warning letters from defense counsel advising them of their noncompliance and reminding them of possible dismissal by the Court, approximately 1,015 plaintiffs remained in default.8 These delinquencies remained largely uncured despite several conferences at which the PEC and the defendants worked with the Court on drafting an order that would secure compliance.9 Finally, the Court issued PTO 208 on November 11, 2003.

1. The Extended Compliance Deadline

PTO 208 granted a final opportunity for compliance to the 1,015 plaintiffs who remained in default under PTO 2.10 It granted an additional 45 days to these plaintiffs to serve complete Fact Sheets11 and warned unequivocally that the Court would treat noncomplianee under PTO 208 as a “willful failure” to obey its discovery orders that could result in dismissal on the merits with prejudice and injunctive relief. The order provided in relevant part:

“1. If any plaintiff identified in Attachment 1 does not serve a fully completed Fact Sheet, including all necessary documents and authorizations on Defendants’ Counsel (Kaye Scholer LLP) within forty-five (45) days of the date of this Order, this Court, upon motion, may dismiss the delinquent plaintiffs action with prejudice and/or impose other sanctions, which may include monetary penalties, based upon that plaintiffs willful failure to comply with the Court’s discovery orders.
“2. Dismissals made under the Order will be on the merits with the intent that any further claim by a dismissed plaintiff arising as a consequence of his or her treatment with Rezulin shall be precluded.
“3. The Court also may issue an injunction pursuant to the All Writs Act, 28 U.S.C. § 1651, enjoining plaintiffs and their counsel from re-filing in any court any claim or action so dismissed.”12

The order included also a provision that required counsel for plaintiffs who were in default under PTO 208, and against whom defendants had moved to dismiss, to provide their client(s) with a copy of PTO 208 within 21 days of the filing the motion and to advise their elient(s) of the sanctions that could follow in the event of their continued noncompliance.13

In sum, PTO 208 granted the 1,015 delinquent plaintiffs a final 45-day grace period, thus fixing a deadline of December 19, 2003 for those subject to the order. Plaintiffs then received an additional three-week extension courtesy of defendants, who notified counsel for all affected plaintiffs that, in view of the various holidays, completed Fact Sheets would be considered timely if submitted by January 9, 2004.14

2. Effect of PTO 208

PTO 208 was not entirely without effect. Following its issuance, the number of non-[113]*113compliant plaintiffs decreased from 1,015 to fewer than 500. As of late February 2004, however, more than 400 remained delinquent. Of these, most had served no Fact Sheets at all. Some had served Fact Sheets lacking the requisite sworn declarations and/or medical authorizations, deficiencies that are material.

Free access — add to your briefcase to read the full text and ask questions with AI

In re Rezulin Products Liability Litigation, 223 F.R.D. 109, 2004 WL 1383549 (S.D.N.Y. 2004).

223 F.R.D. 109 (In re Rezulin Products Liability Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related